跳至主要内容
临床试验/CTRI/2026/03/105176
CTRI/2026/03/105176尚未招募2 期

SINGLE CENTRIC PHASE II OPEN CLINICAL TRIAL IN SWASAKASAM (BRONCHIAL ASTHMA) WITH SIDDHA MEDICINE “EELAI ERUMAL CHOORANAM”

Dr P Hema1 个研究点 分布在 1 个国家目标入组 44 人开始时间: 2026年5月18日最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
44
试验地点
1

研究概览

简要总结

This is single Centric Phase 2 open clinical trial in swasakasam  ( Bronchial Asthma ) With Siddha Medicine Eelai Erumal Chooranam

The Dosage of Eelai erumal chooranam is 1 gram with honey ( Twicw a Day ) for 48 Days

The sample Size for the study is 44

Outcome is mainly assessed by

Reduction in clinical symptoms after treatment

The Outcome is to improve the baseline Spirometry parameter scores.

研究设计

研究类型
Interventional
分配方式
Na
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 50.00 Year(s)(—)
性别
All

入选标准

  • Moderate cases of Bronchial Asthma as Evaluated by Spirometry Assessment FEV1 FVC PEF 60 TO 80 Percentage Ratio of FEV1 and FVC Less than 0.75.

排除标准

  • AGE Greater than 50 YEARS Other systemic illness Vulnerable population Known case of Bronchiectasis and Pulmonary TB Subject who are unwilling or unable to comply with the trial protocol.

研究者

发起方
Dr P Hema
申办方类型
Government medical college
责任方
Principal Investigator
主要研究者

Dr P HEMA

GOVERNMENT SIDDHA MEDICAL COLLEGE, CHENNAI

研究点 (1)

Loading locations...

相似试验